Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene

被引：4
|
作者：
Marote, Ana [1 ,2 ]
Pomeshchik, Yuriy [3 ,4 ,5 ]
Collin, Anna [6 ]
Goldwurm, Stefano [7 ]
Lamas, Nuno J. [1 ,2 ,9 ]
Pinto, Luisa [1 ,2 ,8 ]
Salgado, Antonio J. [1 ,2 ]
Roybon, Laurent [3 ,4 ,5 ]
机构：
[1] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
[2] PT Govt Associate Lab, ICVS 3Bs, Braga, Guimaraes, Portugal
[3] Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Stem Cell Lab CNS Dis Modeling, BMC A10, Lund, Sweden
[4] Lund Univ, Strateg Res Area MultiPk, Lund, Sweden
[5] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden
[6] Off Med Serv, Dept Clin Genet & Pathol, Div Lab Med, Lund, Sweden
[7] ASST PINI CTO, Parkinson Inst, Milan, Italy
[8] Behav & Mol Lab, BnML, Braga, Portugal
[9] Braga Hosp, Dept Anat Pathol, Braga, Portugal
来源：
STEM CELL RESEARCH | 2018年 / 28卷
基金：
瑞典研究理事会;
关键词：
D O I：
10.1016/j.scr.2018.01.022
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
The leucine-rich repeat kinase 2 (LRRK2) p.G2019S mutation is the most common genetic cause of Parkinson's disease (PD). An induced pluripotent stem cell (iPSC) line CSC-41 was generated from a 75-year old patient diagnosed with PD caused by a p.G2019S mutation in LRRK2. Skin fibroblasts were reprogrammed using a non-integrating Sendai virus-based technology to deliver OCT3/4, SOX2, c-MYC and KLF4 transcription factors. The generated iPSC line exhibits expression of common pluripotency markers, differentiates into the three germ layers and has a normal karyotype. The iPSC line can be used to explore the association between LRRK2 mutation and PD. (c) 2017 Published by Elsevier B.V.
引用
收藏
页码：44 / 47
页数：4
相关论文
共 50 条
  • [1] Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation
    Chen, Muwan
    Maimaitili, Muyesier
    Buchholdta, Susanne Hvolbol
    Jensen, Uffe Birk
    Febbraro, Fabia
    Denham, Mark
    STEM CELL RESEARCH, 2020, 45
  • [2] Generation of an Induced Pluripotent Stem Cell Line, ICGi043-A, by Reprogramming Peripheral Blood Mononuclear Cells from a Parkinson’s Disease Patient with p.G2019S Mutation in the LRRK2 Gene
    E. V. Grigor’eva
    S. V. Pavlova
    A. A. Malakhova
    E. S. Yarkova
    D. A. Sorogina
    J. M. Minina
    I. V. Miliukhina
    M. A. Nikolaev
    S. N. Pchelina
    S. P. Medvedev
    S. M. Zakian
    Russian Journal of Developmental Biology, 2023, 54 : 72 - 79
  • [3] Generation of an Induced Pluripotent Stem Cell Line, ICGi043-A, by Reprogramming Peripheral Blood Mononuclear Cells from a Parkinson's Disease Patient with p.G2019S Mutation in the LRRK2 Gene
    Grigor'eva, E. V.
    Pavlova, S. V.
    Malakhova, A. A.
    Yarkova, E. S.
    Sorogina, D. A.
    Minina, J. M.
    Miliukhina, I. V.
    Nikolaev, M. A.
    Pchelina, S. N.
    Medvedev, S. P.
    Zakian, S. M.
    RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY, 2023, 54 (01) : 72 - 79
  • [4] Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients
    Felipe Duque, Andres
    Carlos Lopez, Juan
    Benitez, Bruno
    Hernandez, Helena
    Jose Yunis, Juan
    Fernandez, William
    Arboleda, Humberto
    Arboleda, Gonzalo
    COLOMBIA MEDICA, 2015, 46 (03): : 117 - 121
  • [5] Generation and characterization of induced pluripotent stem cells from a Parkinson's disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations
    Oleksy, Christiane
    Massart, Francois
    Goldwurm, Stefano
    Arado, Alessia
    Arena, Giuseppe
    Boussaad, Ibrahim
    Kruger, Rejko
    STEM CELL RESEARCH, 2023, 72
  • [6] Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's disease patients
    Duque Rodriguez, A. F.
    Yunis Londono, J. J.
    Arboleda Granados, H.
    Fernandez Escobar, W.
    Arboleda Bustos, G.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S155 - S155
  • [7] Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p. I2012T mutation
    Lin, Chin-Hsien
    Cheng, Yu-Che
    Lin, Han-I
    Ho, Ming-Ching
    Hsu, Yu-Hung
    Wen, Cheng-Hao
    Ko, Hui-Wen
    Lu, Huai-En
    Huang, Ching-Ying
    Hsieh, Patrick C. H.
    STEM CELL RESEARCH, 2017, 25 : 123 - 127
  • [8] Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation
    Lin, Han-, I
    Cheng, Yu-Che
    Ko, Hui-Wen
    Wen, Cheng-Hao
    Lu, Huai-En
    Huang, Ching-Ying
    Hsieh, Patrick C. H.
    Lin, Chin-Hsien
    STEM CELL RESEARCH, 2019, 37
  • [9] Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
    Gustavsson, Nadja
    Marote, Ana
    Pomeshchik, Yuriy
    Russ, Kaspar
    Azevedo, Carla
    Chumarina, Margarita
    Goldwurm, Stefano
    Collin, Anna
    Pinto, Luisa
    Salgado, Antonio J.
    Klementieva, Oxana
    Roybon, Laurent
    Savchenko, Ekaterina
    STEM CELL RESEARCH, 2019, 34
  • [10] LRRK2 p.G2019S mutation is not common among Alzheimer's disease patients in Brazil
    Santos-Reboucas, Cintia Barros
    Abdalla, Claudia Bueno
    Martins, Paloma Aguia
    Rodrigues Baldi, Fabio Jose
    Santos, Jussara Mendonca
    Motta, Luciana Branco
    de Borges, Margarete Borges
    Silva Souza, Doroteia Rossi
    de Souza Pinhel, Marcela Augusta
    Laks, Jerson
    Goncalves Pimentel, Marcia Mattos
    DISEASE MARKERS, 2009, 27 (01) : 13 - 16
12345